Both KANSL1 and MAPT have been linked to neurodegenerative diseases such as Alzheimer’s disease (AD), Progressive supranuclear palsy (PSP) and PD [21–23]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.